US Stem Cell Inc (USRM)

[Dragon Lady]

" Now that institutional investors have garnered interest. All of the training and new revenue streams, "??

Where, when, who? What "institutional investors"? The 10-K showed DILUTION shares being sold via the same old avenues such as Asher and the Greystone equity draw-down line.

There was about $5K a month TOTAL in sales listed in the 10-K, from ALL sources- the main one being catheters and very little from anything else.

Anything else is pure speculation at this point. The 10-K included a cash and "financing" update right up through the day before it was filed and there was no "new" anything in it- other than Asher being used right up until as late as Feb 19, 2014.

Pure peculation versus what was just printed in the SEC filed, legally binding, audited 10-K?